LBC Advisors Life Science & Biopharm Advisory & Management
LBC AdvisorsLife Science & Biopharm Advisory & Management

About Rainer

 

Dr. Rainer Lichtenberger, MBA, CEO

 

 

Synopsis Business Acumen and Experience

 

Energetic, resultsoriented and accomplished, with over 25

years’ international experience in senior global appointments

in biotech, biopharmaceutical & life science companies,

with most recent tenures as CEO , Managing Director and Executive VP.

Successful set-up and spin-off of project- and technology-focused

companies and establishing high-performance teams to

set and execute business plans. Attracted and managed

venture capital in excess of 40 Mio. € in several companies,

from seed funding to clinical-stage growth financing. Successfully

managed organi­zational growth and re-structuring/refinancing

of technology-based companies.

 

Analytical skills and experience – Extensive, successful negotiation and

deal making experience in technology and product

acquisitions resp. divestments for pharmaceutical and biotech industry.
Directly responsible for over €100 million in upfront deal and multiples in pending

milestones and royalties.

Broad global network, with senior level contacts

in top-tier US and EU biotech and pharmaceutical companies.

 

since 2015

 

 

2008 - 2014

Founder & CEO
Atriva Therapeutics GmbH, Tübingen (D)


CEO & Managing Director

CEVEC Pharmaceuticals GmbH, Cologne (D)

2004 2008

President and CEO

Neuraxo Biopharmaceuticals GmbH, Erkrath, (D)

Since 2004

Founder & CEO

LBC Advisors LP

2002 – 2004

Member of the Executive Commitee,

Business Development & International Marketing,

Merckle-ratiopharm group

1998 – 2002                

VP Global Strategic Marketing Pharma

Merck KGaA Darmstadt (D)

News

Meet LBC at these conferences:

 

 

 

BIotechnologietage, D-Leipzig, April 2016

 

BioEquity, DK-Kopenhagen, May 2016

 

 

Druckversion Druckversion | Sitemap
© LBC Advisors